SELECTIVE ANDROGEN RECEPTOR MODULATORS: A BRIEF NARRATIVE REVIEW

Authors

  • Joseph A. Giandonato PhD, MBA, CSCS, Chestnut Hill College, Philadelphia, PA, USA

DOI:

https://doi.org/10.46827/ejpe.v12i7.6080

Keywords:

selective androgen receptor modulators, SARM, anabolic androgenic steroids, AAS, ergogenic aids

Abstract

The popularity of Selective Androgen Receptor Modulators (SARMs) has grown among members of the fitness community. Reports of usage have increased in recent years due to their alleged comparable efficacy to anabolic androgenic steroids (AAS), commercial availability, relative ease of procuring constituents sold as research chemicals, and oral bioavailability. In spite of these perceived benefits, the use of SARMs is encumbered by immense health risks. The composition, pharmacokinetics, route of administration, potential clinical uses, and dangers associated with illicit use will be presented in this brief narrative review.

 

Article visualizations:

Hit counter

Author Biography

  • Joseph A. Giandonato, PhD, MBA, CSCS, Chestnut Hill College, Philadelphia, PA, USA

    Joseph A. Giandonato, PhD, MBA, CSCS is an Adjunct Professor of Health and Exercise Science at Chestnut Hill College in Philadelphia, Pennsylvania, USA. His research interests include physical activity and neurocognition, investigating health behaviors of non-traditional students, concurrent training, and ergogenic aids.

    ResearchGate: https://www.researchgate.net/profile/Joseph-Giandonato-2

References

Aktar, N., Locke, D., & Stine, J. (2021). Harm by SARM: A case of drug-induced liver in-jury in an amateur bodybuilder. The American Journal of Gastroenterology, 116(1), S1184. http://dx.doi.org/10.14309/01.ajg.0000784936.08024.c4

Anderson, J. (2022, June 22). Cardinals WR DeAndre Hopkins reveals what led to PED suspension. Arizona Sports. https://arizonasports.com/story/3186320/cardinals-wr-deandre-hopkins-reveals-what-led-to-ped-suspension/?show=comments

Basaria, S., Collins, L., Dillon, E.L., Orwoll, K., Storer, T.W., Miciek, R., Ulloor, J., Zhang, A., Eder, R., Zientek, H., Gordon, G., Kazmi, S., Sheffield-Moore, M., & Bhasin, S. (2013). The safety, pharmacokinetics, and effects of LGD-4044, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 68(1), 87-95. https://doi.org/10.1093/gerona/gls078

Burmeister, M.A., Fincher, T.K., & Graham, W.H. (2020). Recreational use of selective androgen receptor modulators. US Pharmacist, 45(60), 15-18.

Caron, E. (2019, July 24). Titans’ Taylor Lewan gets emotional explaining failed drug test, suspension. Sports Illustrated. https://www.si.com/nfl/2019/07/24/titans-taylor-lewan-suspended-four-games-failed-drug-test-polygraph

Demircan, T., Yavuz, M., & Bölük, A. (2023). Andarine plays a robust in-vitro anti-carcinogenic role on A549 cells through inhibition of proliferation and migration, and activation of cell-cycle arrest, senescence, and apoptosis. Research Square. http://dx.doi.org/10.21203/rs.3.rs-2776621/v1

Efimenko, I.V., Chertman, W., Masterson, T.A., Dubin, J.M., & Ramasamy, R. (2021). Analysis of the growing public interest in selective androgen receptor modula-tors. Andrologia, 53(11), e14238. https://doi.org/10.1111/and.14238

Hahamyan, H.A., Vasireddi, N., Voos, J.E., & Calcei, J.G. (2022). Social media’s impact on widespread SARMs abuse. The Physician and Sportsmedicine, 51(4), 291-293. https://doi.org/10.1080/00913847.2022.2078679

Hilkens, L., Cruyff, M., Woertman, L., Benjamins, J., & Evers, C. (2021). Social media, body image and resistance training: Creating the perfect ‘me’ with dietary sup-plements, anabolic steroids and SARMs. Sports Medicine Open, 7, 81. https://doi.org/10.1186/s40798-021-00371-1

Hoffman, J. (2014). Physiological aspects of sport training and performance (2nd ed.). Human Kinetics, Champaign.

Horwitz, H., Andersen, J.T., & Dalhoff, K.P. (2018). Health consequences of androgenic anabolic steroid use. Journal of Internal Medicine, 285(3), 333-340. https://doi.org/10.1111/joim.12850

Jayaraman, A., Christensen, A., Moser, V.A., Vest, R.S., Miller, C.P., Hattersley, G., & Pike, C.J. (2014). Selective androgen receptor modulator RAD140 is neuroprotec-tive in cultured neurons and kainite-lesioned rats. Endocrinology, 155(4), 1398-1406. https://doi.org/10.1210/en.2013-1725

Joshi, A., Kaune, D. F., Leff, P., Fraser, E., Lee, S., Harrison, M., & Hazin, M. (2024). Self-reported side effects associated with selective androgen receptor modulators: a social media data analysis (preprint). Journal of Medical Internet Research, 27, e65031. https://doi.org/10.2196/65031

Machek, S.B., Cardaci, T.D., Wilburn, D.T., & Willoughby, D.S. (2020). Considerations, possible contraindications, and potential mechanisms for deleterious effect in recreation and athletic use of selective androgen receptor modulators (SARMs) in lieu of anabolic androgenic steroids: A narrative review. Steroids, 164, 108753. https://doi.org/10.1016/j.steroids.2020.108753

Mahoney, J. (2017, March 28). Suspended Joakim Noah says using supplement to aid injuries ‘backfired’. NBA. https://www.nba.com/news/joakim-noah-suspension-supplement-backfired

Mohamed, W.T., Jahagirdar, V., Fatima, I., Ahmed, M.K., Jaber, F., Wang, K., Hassan, A., Ewing, E., Clarkston, W., & Likhitsup, A. (2023). Selective androgen receptor modulators (SARMs)-induced liver injury: A case report and review of literature. Cureus, 15(2), e35094. https://doi.org/10.7759/cureus.35094

Mohan, D., Rossiter, H., Watz, H., Fogarty, C., Evans, R.A., Man, W., Tabberer, M., Beerahee, M., Kumar, S., Millns, H., Thomas, S., Tal-Singer, R., Russell, A.J., Hol-land, M.C., Akinseye, C., Neil, D., & Polkey, M.I. (2023). Selective androgen re-ceptor modulation for muscle weakness in chronic obstructive pulmonary dis-ease: A randomised controlled trial. Thorax, 78(1), 258-266. https://doi.org/10.1136/thorax-2021-218360

Morimoto, M., Aikawa, K., Hara, T., & Yamaoka, M. (2017). Prevention of body weight loss and sarcopenia by a novel selective androgen receptor modulator in cancer cachexia models. Oncology Letters, 14(6), 8066-8071. https://doi.org/10.3892/ol.2017.7200

Narayanan, R., Coss, C.C., & Dalton, J.T. (2018). Development of selective androgen re-ceptor modulators (SARMs). Molecular and Cellular Endocrinology, 465(1), 134-142. https://doi.org/10.1016/j.mce.2017.06.013

Neil, D., Clark, R.V., Magee, M., Billiard, J., Chan, A., Xue, Z., & Russell, A. (2018). GSK2881078, a SARM, produces dose-dependent increases in lean mass in healthy older men and women. Journal of Clinical Endocrinology and Metabolism, 103(9), 3215-3224. https://doi.org/10.1210/jc.2017-02644

Padappayil, R.P., Arjun, A.C., Acosta, J.V., Ghali, W., & Mughal, M.S. (2020). Acute my-ocarditis from the use of selective androgen receptor modulator (SARM) RAD-140 (Testolone). Cureus, 14(1), e21663. https://doi.org/10.7759/cureus.21663

Patt, M., Beck, K.R., Di Marco, T., Jäger, M., González-Ruiz, V., Boccard, J., Rudaz, S., Hartmann, R.W., Salah, M., van Koppen, C.J., Grill, M., & Odermatt, A. (2020). Profiling of anabolic androgenic steroids and selective androgen receptor modu-lators for interference with steroidogenesis. Biochemical Pharmacology, 172, 113781. https://doi.org/10.1016/j.bcp.2019.113781

Pokrywka, A., Obmiński, Z., Malczewska-Lenczowska, J., Fijałek, Z., Turek-Lepa, E., Grucza, R. (2014). Insights into supplements with Tribulus terrestris used by ath-letes. Journal of Human Kinetics, 8(41), 99-105. https://doi.org/10.2478/hukin-2014-0037

Thevis, M., & Schänzer, W. (2018). Detection of SARMS in doping control analysis. Mo-lecular and Cellular Endocrinology, 464(1), 34-45. https://doi.org/10.1016/j.mce.2017.01.040

Downloads

Published

2025-06-19

Issue

Section

Articles